22 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) rose 23.7% to $3.18 in pre-market trading after jumping 10% on Monday. The company, last month, priced its IPO at $10 per unit.
GlaxoSmithKline, Vir Biotechnology Announced Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc.
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Here's a roundup of top developments in the biotech space over the last 24 hours.
Vir Biotech – GSK’s COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced an update to
GlaxoSmithKline, Vir Said Sotrovimab Retains its Activity vs Omicron Variant
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology, Inc.
Why Did HC Wainwright Beef Up Vir Biotech’s Target Price?
H.C. Wainwright has raised the Vir Biotechnology Inc (NASDAQ:VIR) price target to $200 from $135, suggesting an upside of 330%. Analyst Patrick Trucchio…
Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded down 0.88% to 34,827.81 while the NASDAQ fell 0.78% to 15,659.31. The S&P also fell, dropping 0.3832% to 4,616.53.